Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 8:10 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 913–936 of 1,743 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Cardiovascular Risks Clear all

Conditions: Cancer
Interventions: Cardiac Aggressive Risk MitigAtion Plan; Other
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Hypercholesterolemia, Coronary Disease, Primary Health Care, Management, Risk
Interventions: HeartAge intervention; Behavioral
Lead sponsor: Memorial Hospital of Rhode Island; Other
Eligibility: 18 Years to 80 Years
Enrollment: 5,218 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2008
U.S. locations: 1
States / cities: Pawtucket, Rhode Island

Conditions: Cardiovascular Disease
Interventions: AZD0780, Placebo; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years and older
Enrollment: 15,100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 357
States / cities: Athens, Alabama • Birmingham, Alabama • Fairhope, Alabama + 284 more

Conditions: Physical Inactivity, Cardiovascular Risk Factor, Obesity, Blood Pressure, PreDiabetes
Interventions: ActiveGOALSv2, PAT; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 40 Years to 70 Years
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Obesity
Interventions: high caloric expenditure exercise, low caloric expenditure exercise plus dietary counseling; Behavioral
Lead sponsor: University of Vermont; Other
Eligibility: 21 Years to 90 Years
Enrollment: 74 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2007
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Overweight
Interventions: Weight loss; Dietary Supplement
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 19 Years to 50 Years
Enrollment: 53 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Accidental Falls, Fall Due to Loss of Equilibrium, High Risk of Falls Due to Mobility Limitation, Diabetes, Arthritis, Cancer, Peripheral Arterial Disease, Parkinson's Disease, End Stage Renal Failure on Dialysis
Interventions: MBB AFO, Control; Device · Other
Lead sponsor: Bijan Najafi, PhD; Other
Eligibility: 65 Years and older
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Multiple Myeloma, Heart Disease Risk Factors
Interventions: Oncology-Embedded Cardiovascular Risk Assessment Pathway, Primary Care Provider-Directed Cardiovascular Risk Assessment Pathway; Other
Lead sponsor: University of Vermont Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2028
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Cerebral Palsy, Developmental Delay, Stroke, Fine Motor Delay, Infant Development, Other Development Delays
Interventions: SmarToyGym; Device
Lead sponsor: University of Pennsylvania; Other
Eligibility: 3 Months to 11 Months
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2022
U.S. locations: 2
States / cities: Philadelphia, Pennsylvania

Conditions: Tachyarrhythmia
Interventions: ICD; Device
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 18 Years and older
Timeline: 2003 – 2005
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Cancer, Cardiovascular Diseases, Weight Management, Pain, Fatigue, Distress, Emotional, Physical Inactivity
Interventions: HEALTHY AYA, Education Control; Behavioral · Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 39 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Stroke, Hypertension, Diabete Mellitus, Dyslipidemias, Sleep Disorder, Smoking, Overweight and Obesity, Familial Alzheimer Disease, Atrial Fibrillation, Cardiac Disease, Cognitive Impairment, Transient Ischemic Attack
Interventions: DELPhI system; Device
Lead sponsor: QuantalX Neuroscience; Industry
Eligibility: 50 Years to 75 Years
Enrollment: 335 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 3
States / cities: Walnut Creek, California • Atlanta, Georgia • Norwood, Ohio

Conditions: Heart Disease, Atrial Fibrillation
Interventions: Not listed
Lead sponsor: Emile Daoud; Other
Eligibility: 18 Years and older · Female only
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Infant Development, Infant,Premature, Hydrocephalus, Neonatal Encephalopathy, Infarction, PVL, Thrombosis, Intraventricular Hemorrhage
Interventions: pacifier-activated device; Device
Lead sponsor: Nationwide Children's Hospital; Other
Eligibility: 32 Weeks to 12 Months
Enrollment: 130 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Diabetes, Diet, Epidemiology, Stroke, Myocardial Infarction
Interventions: Not listed
Lead sponsor: University of Miami; Other
Eligibility: 40 Years and older
Enrollment: 3,497 participants
Timeline: 1993 – 2022
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Hypercholesteremia
Interventions: phytosterol; Drug
Lead sponsor: The Cooper Institute; Other
Eligibility: 20 Years to 70 Years
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2005
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Coronary Artery Disease, Sleep Disorder; Breathing-Related, Sleep Disorder; Insomnia Type
Interventions: Polysomnograpy, actigraphy; Diagnostic Test
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 99 Years
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Multiple Myeloma
Interventions: aMIL, No aMIL; Biological · Drug
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Years to 80 Years
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: rituximab, cyclophosphamide; Biological · Drug
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Years to 120 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Postmenopausal Women
Interventions: soy nuts; Other
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 21 Years and older · Female only
Enrollment: 84 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2001 – 2012
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Metabolic Syndrome, Cardiovascular Disease
Interventions: BOLD Diet, BOLD-X Diet, Modified DASH Diet; Dietary Supplement
Lead sponsor: Penn State University; Other
Eligibility: 30 Years to 60 Years
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: University Park, Pennsylvania

Conditions: Coronary Artery Disease, Atrial Fibrillation, Type 2 Diabetes, Colorectal Cancer, Breast Cancer, Prostate Cancer
Interventions: Polygenic risk score (PRS); Diagnostic Test
Lead sponsor: Boston VA Research Institute, Inc.; Other
Eligibility: 50 Years to 70 Years
Enrollment: 1,071 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Carotid Artery Disease
Interventions: Not listed
Lead sponsor: Cordis US Corp.; Industry
Eligibility: 18 Years and older
Enrollment: 21,008 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2014
U.S. locations: 5
States / cities: Newark, Delaware • West Des Moines, Iowa • Lincoln, Nebraska + 2 more

Conditions: Venous Thromboembolism
Interventions: Not listed
Lead sponsor: Sanofi; Industry
Eligibility: 40 Years and older
Enrollment: 21,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Bridgewater, New Jersey

Search by objective public record fields.

Cardiac Aggressive Risk Mitigation in Thoracic Radiotherapy (CARMA) Trial

Translating ATP III Cholesterol Management Guidelines Into Primary Care Practice

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

The Clinical Referral to Activity Study

Methods of Weight Loss in Overweight Coronary Patients

Effects of Medium Chain Triglyceride Oil, Versus Olive Oil, for Weight Loss

OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO

MM-CARE: Cardiovascular Risk Assessment in Adults With Multiple Myeloma

SmarToyGym: Smart Detection of Atypical Toy-oriented Actions in At-risk Infants

ASSURE Study - Arrhythmia Single Shock DFT Versus ULV: Risk Reduction Evaluation With ICD Implantations

Healthy Lifestyles After Cancer for Adolescents and Young Adults: A Program to Reduce Cardiovascular Risk Factors

DELPHI in Subjects at Risk for Stroke and Dementia

Data Collection and Analysis of Patients Who Have Had an Electrophysiological Procedure

Pacifier Activated Device and Mother's Voice in Infants at High-risk for Cerebral Palsy

Stroke Incidence and Risk Factors in a Tri-ethnic Region

Phytosterol Supplementation and Cardiovascular Risk

Comorbid Insomnia and Sleep Disordered Breathing in Patients Undergoing Cardiac Rehabilitation

Tadalafil and Lenalidomide Maintenance With or Without Activated Marrow Infiltrating Lymphocytes (MILs) in High Risk Myeloma

Rituximab and Cyclophosphamide in Treating Patients With High Risk, Refractory, or Relapsed Multiple Myeloma

Soy Nuts and Cardiovascular Risk in Postmenopausal Women

Beef in an Optimal Lean Diet (BOLD) Effects on Metabolic Syndrome

The Genomic Medicine at VA Study

SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy

Comparison of the Risk of Venous Thromboembolism (i.e., Blood Clots in the Veins) and Bleeding Events in a Population of Obese Patients Receiving Higher-Dose or Extended-Duration Versus Conventional-Dose or Conventional-Duration of Prophylaxis (i.e., Preventive Treatment) With Enoxaparin